News and updates
GMS has signed distribution agreement with Illumina
Global Marketing Services is a leading and distinguished medical company in Pakistan. GMS is serving the health industry since 2000, we have steadily expanded our line of products and created a presence in various diagnostic markets.
Today we are very pleased to announce that we have signed a distribution agreement with Illumina, USA, A Global Leader for Next Generation Sequencing (NGS), for the Pakistan market.
Illumina is the global leader in the manufacturing of Next Generation Sequencing systems used by life sciences and researchers to isolate and analyze genes. Illumina has an almost 75% global market share in the genetic sequencing industry.
Illumina’s proprietary microarray (Bead Array) technology uses microscopic silica beads that can carry samples through the genotyping process. The tests allow medical researchers to determine what genetic combinations are associated with various diseases, enabling faster diagnosis, better drugs target, and individualized treatment.
We believe that NGS will trigger a fundamental shift in the practice of medicine and health care in Pakistan, and the increased emphasis on preventive and predictive molecular medicine will usher in the era of precision health care.
With Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission-critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our valued customers. For this, we have established a dedicated team of highly qualified, trained, and experienced team members across Pakistan, that will bring this technology within your reach.
